Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

CS MEDICA's Joint Venture with RongShi Successfully Represented at CPHI & PMEC China 2023

CS MEDICA and RongShi strengthened the progress of their Joint Venture on its second Joint Fair at CPHI & PMEC in Guangzhou ,China 2023 (September 4-6), Asia's premier pharma event. CS MEDICA, a leading MedTech company specializing in Cannabis and Pain Management, is excited to provide an update of its Joint Venture, RongShi MEDICA (Ordos) Co., Ltd. ("RongShi MEDICA", "JV" or "Joint Venture") - the Joint Venture partnership between CS MEDICA ("CS MEDICA" or "the Company") and Inner Mongolia Rong Shi Hi-Tech Co., Ltd (“RongShi”).   The Joint Venture has successfully participated

Scape Technologies and Cobots Sweden AB Establish New Partnership

Scape Technologies has formed a new partnership with Cobots Sweden AB , also known as 'COBOTS - The One Stop Shop for Collaborative Applications'. As part of this extended collaboration, COBOTS  has placed an order for a SCAPE Mini-Picker  solutionCOBOTS  specializes in the distribution of collaborative robots and related accessories. Leveraging their extensive expertise in robot integration and automation, COBOTS  offers valuable guidance on how businesses

Raisio plc: Managers´ transactions

Raisio plc Managers´ transactions 6 September 2023   MANAGERS’ TRANSACTIONS   Person subject to the notification requirement Name: Annika Boström-Kumlin Position: Other senior manager Issuer: Raisio Oyj LEI: 74370083282NHIP4QD02   Notification type: INITIAL NOTIFICATION Reference number: 37426/4/4 ____________________________________________   Transaction date: 2023-09-05 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI0009002943 Nature of transaction: ACQUISITION (X) Executed under portfolio or asset management

Update on US review of Ultomiris for NMOSD

6 September 2023 Update on US regulatory review of Ultomiris in NMOSD The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) regarding the supplemental Biologics License Application (sBLA) for long-acting C5 complement inhibitor Ultomiris (ravulizumab-cwvz) for the treatment of adult patients with neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin-4 (AQP4) antibody positive (Ab+). The CRL did not request additional analysis or reanalysis of the Phase III CHAMPION-NMOSD trial data included in the sBLA submission and did not raise

Compliance with Market Abuse Regulations

Fidelity Asian Values PLC (“the Company”) LEI: 54930094CXNYINSNOQ96   Compliance with Market Abuse Regulations     The Company wishes to notify the market that the closed period of the Company in relation to its annual results for the financial year ended 31 July 2023 will commence on 6 September 2023 and is anticipated to end no sooner than 6 October 2023.   The Company confirms that all inside information (as defined in the EU Market Abuse Regulation) which the Directors and the Company may have held has been notified to a regulatory information service.

Cell Impact participates in the Stuttgart hy-fcell conference and exhibition

Cell Impact participates in hy-fcell in Stuttgart, Germany, one of the world’s largest and most important hydrogen technology industry events. Cell Impact will present the company’s flow plate production offer based on the unique forming technology Cell Impact Forming[TM].Flow plate production is critically important for the growth of the hydrogen industry and at hy-fcell, Cell Impact will share its experiences and knowledge from more than 50 flow plate projects involving a wide range of applications and materials. Cell Impact’s production offer involving Cell Impact Forming, an

Betsson successfully issues bonds of EUR 75 million

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA) OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) (THE "SECURITIES ACT") OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT. THE DISTRIBUTION OF THIS DOCUMENT IN CERTAIN JURISDICTIONS (IN PARTICULAR,

Akobo Minerals secures NOK 34.4 million in funding through a convertible loan

OSLO, 06 September 2023: Akobo Minerals AB (publ) (Euronext and Frankfurt: AKOBO), the Scandinavian-based Ethiopian gold exploration and boutique mining company, today announced that it has issued an unsecured convertible loan (the "Loan") of NOK 34.4 million (approx. USD three million) from existing investors to fund the final phase of its Segele mining operation in Gambella, Ethiopia. The board of directors and management of Akobo Minerals contributed with NOK 4.7 million of the funds.     The proposed Loan has a term of two years and an interest rate of 20 % p.a. The Loan may be

Stayble Therapeutics terminates agreement regarding liquidity provider

Stayble Therapeutics AB ("Stayble" or "the Company") announces today that the Company has terminated the agreement regarding the liquidity provider with Lago Kapital AB ("Lago"). The agreement will cease to be effective on September 29, 2023.The purpose of the liquidity provider has been to increase the liquidity of stock trading and reduce the volatility of the Company's stock to facilitate trading. Stayble assesses that the liquidity of the stock is strong and that the need for a liquidity provider is no longer applicable. The agreement with Lago has now been terminated and will expire on

Faron Pharmaceuticals Ltd. to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Faron Pharmaceuticals Ltd. to Present at the H.C. Wainwright 25th Annual Global Investment Conference     TURKU, Finland / BOSTON, Massachusetts – September 6, 2023 – Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, today announces that Dr Markku Jalkanen, PhD, CEO will present at the H.C. Wainwright Annual Global Investment Conference in New York City on September 12, 2023.  In addition to the presentation, company management will be available for one-on-one meetings with

Catena Media announces outcome of warrants exercised post-Q2 2023 report subscription period

Catena Media plc (“Catena Media” or the “company”) today announces the outcome of the subscription period following the publication of the interim report for the second quarter of 2023 (“subscription period”) of the warrants 2020/2024 (“warrants”) issued as part of the rights issue of units. Exercise of warrants A total of 3,462 warrants, corresponding to approximately 0.01 percent of all outstanding warrants (being approximately 0.01 percent of all warrants issued as part of the rights issue), were used to subscribe for the same number of new ordinary shares in the company. The

Changes in Metsä Board’s Corporate Management Team

Metsä Board Corporation Stock exchange release Changes board/management/auditors 6 September 2023 at 09:00 EESTAri Kiviranta, SVP, Technology and a member of the Corporate Management Team, has decided to leave his position at Metsä Board and retire. Kiviranta will continue in his position until 31 October 2023. Kiviranta's responsibilities will be transferred to Harri Pihlajaniemi, currently SVP, Production and a member of the Corporate Management Team. Pihlajaniemi will take up the position of SVP, Production and Technology as of 1 November 2023. Pihlajaniemi will continue to be a member

Devyser and Thermo Fisher Scientific expand the collaboration for post-transplant NGS products by adding Brazil

Devyser and Thermo Fisher Scientific have agreed to expand commercial collaboration by including Brazil in the exclusive collaboration and distribution agreement for Devyser’s post-transplant portfolio of NGS products. In addition to North America and Europe, Thermo Fisher will now exclusively market and sell Devyser’s transplantation products under combined brands also in Brazil.     “We are very excited to enter into this agreement. Up to now, our products have not been available in the large Brazilian market, and we are highly optimistic about future sales in the country, which has

Norse Atlantic Airways Launches Ticket Sales For New Route Between Paris and Los Angeles

· New route will commence on 1[st] May 2024 · Flights will operate six times a week · Fares start from €319 one-way including all taxesNorse Atlantic Airways, the pioneering low-cost long-haul airline, is thrilled to announce the commencement of ticket sales for its direct route between Paris and Los Angeles. This new service, operating six times a week, is set to commence on 1[st] May 2024 and is available to book immediately on www.flynorse.com Flights depart Paris (CDG) at 16.15 and arrive at Los Angeles (LAX) at 19.05. Flights depart Los Angeles at 21.10 and arrive at Paris at

Nordea Bank Abp flagging notification: BlackRock Inc.’s shareholding crosses threshold of five percent

Nordea Bank AbpStock exchange release – Major shareholder announcements6 September 2023 at 9.00 EET BlackRock, Inc.'s indirect shareholding of Nordea Bank Abp’s shares and voting rights has crossed the threshold of five percent, according to a notification Nordea received on 5 September 2023 under Chapter 9, Section 10 of the Securities Markets Act (SMA). The threshold was crossed on 4 September 2023. The total number of shares and voting rights in Nordea Bank Abp is 3,569,745,018. Total positions of BlackRock, Inc. and its funds according to the notification: +--------------

Neste's Shareholders' Nomination Board appointed

Neste Corporation, Stock Exchange Release, 6 September 2023 at 9 a.m. (EET) The following members have been appointed to Neste's Shareholders' Nomination Board: The Chair, Senior Ministerial Adviser, Financial Affairs Maija Strandberg of the Ownership Steering Department in the Prime Minister’s Office of Finland; Timo Sallinen, Senior Vice President, Investments of Varma Mutual Pension Insurance Company; President and CEO Jouko Pölönen of Ilmarinen Mutual Pension Insurance Company and Matti Kähkönen, the Chair of  Neste's Board of Directors. I 

Nordic customer expands payroll services with Zalaris

Zalaris, the provider of Payroll and HR Solutions that simplify work life and support creating sustainable businesses, today announced that a customer in the Nordics has expanded their payroll services with Zalaris to cover  an additional country serving an additional 10,000 employees.Zalaris will deliver a PeopleHub based Payroll  and Time & Attendance Solution  as Software as a Service (SaaS). The solution includes portal and mobile enabled self-services offering

Finnair Traffic Performance in August 2023

Finnair Plc                Investor News              6 September 2023 at 9:00 a.m. EEST Close to one million passengers and solid passenger load factor In August, Finnair carried 969,800 passengers, which was 10.1% more than in August 2022 but 8.7% less than in July 2023. August passenger traffic figures improved year-on-year as the COVID-19 pandemic impacts have mostly faded and as the Russian airspace was closed already during the comparison period. The negative impact of the Russian airspace closure especially on Asian passenger traffic figures was, however, still visible in

Stora Enso’s Shareholders’ Nomination Board composition

STORA ENSO OYJ STOCK EXCHANGE RELEASE 6 September 2023 at 9:00 EESTThe Stora Enso Shareholders’ Nomination Board has been established to exist until otherwise decided. The Shareholders’ Nomination Board annually prepares proposals for Stora Enso Oyj’s Annual General Meeting concerning the election and remuneration of members of the Stora Enso Board of Directors and Board committees, as well as the appointments of the Chair and the Vice Chair of the Board of Directors. The Shareholders’ Nomination Board consists of the Chair of Stora Enso’s Board of Directors, the Vice Chair of the Board of

Stora Enso shares converted

STORA ENSO OYJ STOCK EXCHANGE RELEASE 6 September 2023 at 9:00 EESTDuring the 1–31 August 2023 conversion period there were two conversions and a total of 726 A shares were converted into R shares. The shares were recorded in the Finnish trade register today, 6 September 2023, and trading in the new R shares will start on 7 September 2023.Breakdown of shares after conversion:A shares     176,231,946R shares     612,388,041Total           788,619,987Each A share and each ten R shares carry one vote. The total amount of votes after the conversion is at least 237,470,750.For

Arne Hauge joins Bio-Works as Chief Financial Officer

Bio-Works announces today that Arne Hauge has joined the company as Chief Financial Officer. He is joining as a member of Bio-Works executive team and will report directly to CEO, Jonathan Royce.As CFO at Bio-Works Arne Hauge will be responsible for financial management of the company, including leadership of the company’s planning processes, and he will work together with management team to drive Bio-Works to the next stage of growth.  Arne Hauge’s latest position was with Felestad Trading AB, as Interim CFO. Arne is a business driven and strategic CFO, with experience from two start-

The wellbeing services county of Central Finland participates in the joint development of Tietoevry's Lifecare client and patient information system

Two years ago, Tietoevry launched a partnership model for the development of its Lifecare client and patient information system. In this model Lifecare is developed in cooperation with the Finnish wellbeing services counties based on the needs of their health and social care professionals. The wellbeing services county of Central Finland now joins the work to implement high-quality and cost-effective health and social care services. The South Karelia, South Ostrobothnia, Kanta-Häme, Central Ostrobothnia, Kymenlaakso, Päijät-Häme and Satakunta counties are already involved in the model. The

Nightingale Health to provide blood sample analysis service for a large U.S. healthcare system

Press release, 6 September 2023 at 8:30 a.m. (EEST)    Nightingale Health Plc (“Nightingale Health”), a pioneer in health risk detection and preventative health, has entered into an agreement in which Mass General Brigham orders analysis services for blood samples from Nightingale Health.   Mass General Brigham’s institutions are known for their research-infused care, and the agreement will make critical biomarker data available to researchers as they work to bring scientific findings to the healthcare setting in an effort to improve patient outcomes.   “The Mass General

Raisio plc: Raisio's converted shares

Raisio plc  Stock Exchange Release, 6 September 2023   RAISIO'S CONVERTED SHARES   The Board of Directors of Raisio plc has decided in its meeting held on 23 August 2023 to convert a total of 800 restricted shares (series K) into free shares (series V). The decision has been entered in the Trade Register today, on 6 September 2023. The additional lot of free shares in question is admitted to trading on the Nasdaq Helsinki Ltd as of 7 September 2023.   Since the beginning of 2023, a total of 800 restricted shares of the company have been converted into free shares. The

There are no items matching the current filter
There are no more items matching the current filter
Back to top